Amfora, Inc. is a California-based pharmaceutical company founded with the mission to sustainably nourish the planet and enhance global wellness. The company focuses on developing and manufacturing drugs, leveraging advanced gene-editing technologies to improve the nutrition and sustainability of soy crops. Amfora aims to fuel the plant-based protein revolution, contributing to healthier food options and a healthier planet.
Notable figures affiliated with Amfora include Michael Lassner, who serves as the Chief Science Officer. The company has made significant strides in the field of agricultural biotechnology, particularly in enhancing the nutritional value and sustainability of soy crops. By focusing on innovative solutions to global food and health challenges, Amfora has positioned itself as a key player in the intersection of agriculture and pharmaceuticals, making a meaningful impact on both human health and environmental sustainability.
